8 Sep 2021

System release – New Medicine Service (NMS)

We have updated the system! As some of you may be aware, one of the outcomes for Year 3 of the Community Pharmacy Contractual Framework is an expansion of the New Medicine Service (NMS).

To support our customers, RxWeb has been updated this week so that any newly prescribed medicines dispensed under one of the thirteen new categories and that are listed on the published NMS Drug Lists ( New Medicine Service (NMS) – Drug Lists | NHSBSA ), will be flagged to the user during the dispensing process, subject to you having NMS switched on in your system configuration.

NMS Expansion categories:

  • Acute coronary syndrome (ACS);
  • Atrial fibrillation (AF);
  • Coronary heart disease;
  • Epilepsy;
  • Glaucoma;
  • Gout;
  • Heart failure;
  • Hypercholesterolaemia ;
  • Long term risks of venous thromboembolism/embolism;
  • Osteoporosis;
  • Parkinson’s Disease;
  • Stroke / transient ischemic attack; and
  • Urinary incontinence and retention.

Please note that the current NMS eligible conditions/medicines will also continue as before, but the antiplatelet/anticoagulant therapy group is now included in the above list by reference to the underlying condition/reason for prescribing.

Related news

Embracing Cloud-Based PMR Systems with RxWeb
Clanwilliam is excited to be delivering EPS for our customers in Wales

Clanwilliam are excited to supporting the delivery of Electronic Prescription Service (EPS) in Wales with RxWeb.  We have now entered the testing phase to support the programme.

How RxWeb is delivering the time and support that pharmacy

When considering a PMR partner for your pharmacy, security and how they store data relating to your business should be among your top priorities.